Phase I study of carfilzomib, lenalidomide, vorinostat, and dexamethasone in patients with relapsed and/or refractory multiple myeloma

Publisher: John Wiley & Sons Inc

E-ISSN: 1365-2141|7-1048|1|52-59

ISSN: 0007-1048

Source: BRITISH JOURNAL OF HAEMATOLOGY, Vol.7-1048, Iss.1, 2015-10, pp. : 52-59

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract